Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Reyes, Arranz"'
Autor:
Alejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, Giuseppe Gritti, María Cortés, Silvana Novelli, Carlos Panizo, Luigi Petrucci, Antonio Gutiérrez, Ivan Dlouhy, Mariana Bastos-Oreiro, Juan M. Sancho, María J. Ramírez, José M. Moraleda, Estrella Carrillo, Ana I. Jiménez-Ubieto, Isidro Jarque, Lorella Orsucci, Estefanía García-Torres, Carlos Montalbán, Anna Dodero, Reyes Arranz, Natalia de las Heras, María J. Pascual, Javier López-Jiménez, Michelle Spina, Alessandro Re, Sonia González de Villambrosia, Sabela Bobillo, Massimo Federico, Dolores Caballero
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of rare lymphoid malignancies that mostly have poor prognoses with currently available treatments. Upfront consolidation with autologous stem cell transplantation (ASCT) is frequently carri
Externí odkaz:
https://doaj.org/article/250a8456656f4f6bb3571fe2aa2568f0
Autor:
Jacobo Rogado, Nuria Romero-Laorden, José Miguel Sanchez-Torres, Ana María Ramos-Levi, Vilma Pacheco-Barcia, Ana Isabel Ballesteros, Reyes Arranz, Alicia Lorenzo, Pedro Gullon, Ana Garrido, José María Serra López-Matencio, Olga Donnay, Magdalena Adrados, Pablo Costas, Javier Aspa, Arantzazu Alfranca, Rebeca Mondejar, Ramon Colomer
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Immunotherapy is an effective treatment in advanced cancer, although predictors of response are limited. We studied whether excess weight influences the efficacy outcomes of immunotherapy. We have also evaluated the combined prognostic effect of exce
Externí odkaz:
https://doaj.org/article/c17e72bb7ac94c3c8391d210e75236de
Autor:
Marta López-Nevado, Javier Ortiz-Martín, Cristina Serrano, María A. Pérez-Saez, José L. López-Lorenzo, Francisco J. Gil-Etayo, Edgar Rodríguez-Frías, Oscar Cabrera-Marante, Pablo Morales-Pérez, María S. Rodríguez-Pinilla, Rebeca Manso, Rocío N. Salgado-Sánchez, Ana Cerdá-Montagud, Juan F. Quesada-Espinosa, María J. Gómez-Rodríguez, Estela Paz-Artal, Cecilia Muñoz-Calleja, Reyes Arranz-Sáez, Luis M. Allende
Publikováno v:
Journal of Clinical Immunology. 43:165-180
Autor:
Juan-Manuel Sancho, Ana Marín-Niebla, Silvia Fernández, Francisco-Javier Capote, Carolina Cañigral, Carlos Grande, Eva Donato, Izaskun Zeberio, Jose-Manuel Puerta, Alfredo Rivas, Elena Pérez-Ceballos, Ana Vale, Alejandro Martín García-Sancho, Antonio Salar, Eva González-Barca, Anabel Teruel, Carmen Pastoriza, Diego Conde-Royo, Joaquín Sánchez-García, Cristina Barrenetxea, Reyes Arranz, José-Ángel Hernández-Rivas, María-José Ramírez, Aroa Jiménez, Eva Rubio-Azpeitia
Publikováno v:
INTERNATIONAL JOURNAL OF HEMATOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
International Journal of Hematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-FISABIO. Repositorio Institucional de Producción Científica
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
International Journal of Hematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-FISABIO. Repositorio Institucional de Producción Científica
This retrospective study evaluated 66 patients diagnosed with relapsed and/or refractory mantle cell lymphoma (R/R MCL) treated with ibrutinib in Spain in routine clinical practice. At diagnosis, patients had a median age of 64.5 years, 63.6% present
Autor:
Jorge Gayoso Cruz, Reyes Arranz, Alejandro Martín, Mariana Bastos, Oscar Blanco, Pau Abrisqueta, Gustavo Tapia, Sonia González de Villambrosia, Grupo Español de linfomas y trasplante, Andres Lopez, Ana García-Noblejas, Magdalena Adrados, Javier Menarguez Palanca, Josep Castellví, Sara Alvarez Alonso, Santiago Montes-Moreno, José-Tomás Navarro
Publikováno v:
Leukemia & Lymphoma. 63:101-108
High Grade B Cell Lymphoma, NOS, and High Grade B Cell Lymphoma with Dual Hit or Triple Hit have been recently recategorized in the 2016 revision of the WHO classification of lymphoid neoplasms. In this study we have characterized the genetic, histop
Autor:
Javier Lopez Jimenez, Alejandro Martín, Carmen Albo, Reyes Arranz, Antonia Rodriguez, Luis Palomera, Sabela Bobillo, Lucrecia Yáñez, Isidro Jarque, Dolores Caballero, Armando López-Guillermo, José M. Moraleda, Juan José Lahuerta, Erika Coria, Santiago Mercadal, Carlos Vallejo, Antonio Salar, Laura Magnano, Leyre Lorza, Miguel T. Hernández-García, José Javier Ferreiro, Ana Jiménez-Ubieto, Silvana Novelli, Andrea Galeo, María Manzanares, Carlos Grande, Carmen Marrero, Elena Pérez
Publikováno v:
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Hematology/Oncology and Stem Cell Therapy, Vol 12, Iss 4, Pp 194-203 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Universidad de Zaragoza
Hematology/Oncology and Stem Cell Therapy, Vol 12, Iss 4, Pp 194-203 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Objective/Background: Patients with follicular lymphoma (FL) with early therapy failure (ETF) within 2 years of frontline therapy have poor overall survival (OS). We recently reported the results of autologous stem cell transplantation (ASCT) in pati
Autor:
Bernardo Garichochea, Judit Demeter, Yuankai Shi, Umberto Vitolo, Enrica Morra, Margarida Marques, Miklos Egyed, Toshiki Uchida, Árpád Illés, Kenichi Ishizawa, Cristina Ligia Cebotaru, Ashis Mukhopadhyay, Masafumi Taniwaki, Sung-Soo Yoon, Cristina-Ligia Truica, Cheol Won Suh, Irina Lysenko, Naokuni Uike, Huaqing Wang, Achiel Van Hoof, Maryna Kyselyova, Osmanov Ea, Andrew Belch, Alexy Kuzmin, Caballero Gabarrón, Steven Van Steenweghen, Sergio Cancelado, Olga Samoilova, Kensei Tobinai, Kiyoshi Ando, Susumu Nakahara, Tatiana Scheider, Massimo Federico, Dmitry Udovitsa, Xiaoyan Ke, Yurii Lorie, Tatsu Shimoyama, Weerasak Nawarawong, Sebastian Grosicki, Gregor Verhoef, Nuriet Khuageva, Suporn Chuncharune, Fritz Offner, Albert Oriol Rocafiguera, Charles Farber, Ernst Späth-Schwalbe, Juliana Pereira, Ting Liu, Lee-Yung Shih, Steven Le Gouill, Miklos Udvardy, Richard Greil, Carmen Cao, Tomohiro Kinoshita, Horia Bumbea, Yasuhito Terui, Eva Gonzalez-Barca, Irina Bulavina, Peter Hu, Francisco Javier Capote, Olga Serduk, Akihiro Tomita, Ilseung Choi, Mahmut Gumus, Udomsak Bunworasate, Adriana Teixeira, Vladimir Merkulov, Yeow Tee Goh, Tadeusz Robak, Huiqiang Huang, Jie Jin, Cristina Ileana Burcoveanu, Halyna Pylypenko, Joaquín Díaz, Herlander Marques, Zoltán Gasztonyi, Vijay Rao Phooshkooru, Gayane Tumyan, Maike De Wit, Ali Khojasteh, Marcelo Capra, Vladimir Lima, Dai Maruyama, Viacheslav Pavlov, Georg Heß, Carmino Antonio De Souza, Zhao Wang, Iryna Kryachok, Amel Mezlini, Galvez Cardenas, Marina Golubeva, Lyudmila Kuzina, Patricia Santi, Remy Gressin, Balkis Meddeb, Xiaonan Hong, David Belada, Bernard De Prijck, Jan Maciej Zaucha, Jiri Mayer, Michinori Ogura, Rumiko Okamoto, Dolores, Irit Avivi, Mario Ojeda-Uribe, Grigoriy B Rekhtman, Jun Zhu, Reyes Arranz, Polina Kaplan, André Bosly, Ann Van De Velde, Kenny Mauricio, Yuri Dunaev, Anatoly Golenkov, Oleg Gladkov, Yoshiharu Maeda, Franco Cavalli, Dina Ben Yehuda, Michele Baccarani, Markus Raderer, Razvan Stoia, Carlos Appiani, Zvenyslava Masliak, Zita Borbenyi, Guiseppe Rossi, Julia Alexeeva, Johannes Drach, Kateryna Vilchevskaya, Georgii Manikhas, Jan Novák, Noppadol Siritanaratkul, Zhixiang Shen, Alexander Suvorov, Michael Crump, Pierre Zachee, Ofer Shpilberg, Sepideh Nemat, Mitsutoshi Kurosawa, Sreejith Nair, Bulent Undar, Govind Babu, Kudrat Abdulkadryrov, Adriana Sheliga
Publikováno v:
The Lancet Oncology. 19:1449-1458
Summary Background In the LYM-3002 study, the efficacy and safety of frontline bortezomib plus rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) and rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) were c
Autor:
T. Zuckerman, A. Boumedil, Josep-Maria Ribera, William Arcese, Agostino Cortelezzi, Guido Kobbe, Ian H Gabriel, R. F. Duarte, Eva Domingo-Domenech, D. W. Beelen, Reyes Arranz, Hildegard T. Greinix, Peter Dreger, J. Thompson, Herve Finel, Francesco Onida, Stig Lenhoff, Anna Sureda, Eduardo Olavarria, Ghulam J. Mufti, Hendrik Veelken, Xavier Poiré, Paul Browne, Silvia Montoto
Publikováno v:
Bone Marrow Transplantation. SPRINGERNATURE
Bone Marrow Transplantation
Bone Marrow Transplantation
BACKGROUND Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option in advanced-stage mycosis fungoides (MF) and Sezary syndrome (SS). This study presents an updated analysis of the initial experience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::990eb12e9f8df5847bf43b23c0bfffbb
https://hdl.handle.net/1887/3279512
https://hdl.handle.net/1887/3279512
Autor:
Reyes Arranz, Ana García-Noblejas, Carlos Grande, Jimena Cannata-Ortiz, José J. Sánchez, José-Antonio García-Marco, Concepción Aláez, Javier Pérez-Calvo, Pilar Martínez-Sánchez, Blanca Sánchez-González, Miguel-Angel Canales, Eulogio Conde, Alejandro Martín, Eva Arranz, María-José Terol, Antonio Salar, Dolores Caballero
Publikováno v:
Haematologica, Vol 98, Iss 10 (2013)
The prognosis for fit patients with mantle cell lymphoma has improved with intensive strategies. Currently, the role of maintenance/consolidation approaches is being tested as relapses continue to appear. In this trial we evaluated the feasibility, s
Externí odkaz:
https://doaj.org/article/ed4a27045ae94690b3543b11f8af8e50
Autor:
Vincent Ribrag, Dolores Caballero, Christophe Fermé, Emanuele Zucca, Reyes Arranz, Javier Briones, Christian Gisselbrecht, Gilles Salles, Alessandro M. Gianni, Henry Gomez, Carmen Kahatt, Claudia Corrado, Sergio Szyldergemajn, Sonia Extremera, Bernardo de Miguel, Martin Cullell-Young, Franco Cavalli
Publikováno v:
Haematologica, Vol 98, Iss 3 (2013)
This phase II clinical trial evaluated the efficacy, safety and pharmacokinetics of plitidepsin 3.2 mg/m2 administered as a 1-hour intravenous infusion weekly on days 1, 8 and 15 every 4 weeks in 67 adult patients with relapsed/refractory aggressive
Externí odkaz:
https://doaj.org/article/c58afd14cd994b96ba309fccf26fa18d